Dr. Muhammed Sherid, MD

Dr. Sherid practices at Florida Hospital Healthcare Partners, Inc in Ormond Beach, Florida.

Dr. Sherid's NPI, 1700176088, was assigned on April 7, 2011. Dr. Sherid graduated from Damascus University Faculty of Medicine in 1999. Dr. Sherid holds Florida license ME149118.

Dr. Sherid's primary practice is Florida Hospital Healthcare Partners, Inc, at 907 Sterthaus Dr, Ormond Beach, FL 32174 in Volusia County. The practice phone is (386) 231-6000.

Dr. Sherid's primary practice is Florida Hospital Healthcare Partners, Inc in Ormond Beach, Florida. Dr. Sherid is also affiliated with AdventHealth Daytona Beach. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Sherid to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherid practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sherid's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sherid is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Sherid's licenses on file in 9 states: Florida, Illinois, New Mexico, Arizona, California, Michigan, Maine, Georgia and Wisconsin.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, gastrointestinal bleeding, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Sherid treats.

CMS data shows 2,040 Medicare services from Dr. Sherid across 26 procedure codes in 2024, for 528 Medicare patients. Medicare paid $180,371 for them.

CMS counts 528 Medicare patients who saw Dr. Sherid in 2024. The largest group is 65 to 74, with 266 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherid's median patient age at 72, with 52% women.

In 2024, Dr. Sherid wrote 748 Medicare Part D claims for 343 patients. 88% of them were for generic drugs. CMS names the drug for 561 of them, across 11 drugs with 11 or more claims each, at $60,979 in total drug cost. In 2023, CMS named 378 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sherid for performance year 2024, reported as part of a group. Dr. Sherid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 511 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sherid, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Sherid, published from 2013 to 2018. 2013 was the busiest year, with 3. The most frequent topics are Colitis, Ischemic, Antineoplastic Agents and Colonic Neoplasms. Dr. Sherid has published most often in J Gastrointest Cancer. Dr. Sherid's most frequent co-authors are Husein Husein, MD, Humberto Sifuentes, MD and Parakkal Deepak, MD.

CMS Open Payments shows 103 general payments to Dr. Sherid from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Covidien LP paid the most, $1,037.

Dr. Sherid graduated from Damascus University Faculty of Medicine in 1999. Dr. Sherid is a member of ACG, AGA and ASGE.

Dr. Sherid is in network with 25 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.